1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NCI Investigator-Initiated Early Phase Cancer Clinical Trials Grant is sponsored by National Cancer Institute (NCI). This program provides R01 funding for clinical research evaluating new or improved approaches to cancer diagnosis and treatment.
Research may address anticancer drugs and biologics, immunotherapies, imaging technologies, radiation therapy, surgical interventions, biomarkers, diagnostics, devices, or complementary and integrative approaches relevant to NCI research priorities. Applications must include at least one NIH-defined clinical trial and may involve Phase 0, Phase I, or Phase II studies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Public and private institutions of higher education are eligible. Eligible state, local, tribal, and federal government organizations may apply. Foreign/non-U.S. organizations are eligible. Organizations may submit more than one application provided the proposals are scientifically distinct. New, renewal, resubmission, and revision applications are permitted. Cost sharing or matching funds are not required. Confirm the full requirements in the official notice before applying.
The current listing shows up to $2,499,995 in direct costs over 5 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for NCI Investigator-Initiated Early Phase Cancer Clinical Trials Grant are due October 12, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
NCI Investigator-Initiated Early Phase Cancer Clinical Trials Grant is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
On May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read article